Evidence map›Paper›PMID 31748270›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

A high-resolution landscape of mutations in the

Jiang-Cheng Shen, Ashwini S Kamath-Loeb, Brendan F Kohrn, Keith R Loeb, Bradley D Preston, Lawrence A Loeb

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Detection of mutations: from Ames test to duplex sequencing.Frontiers in molecular biosciences · 2026
    Review
  3. Acta pharmaceutica Sinica. B · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. A high-resolution landscape of mutations in theProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jiang-Cheng ShenDepartment of Pathology, University of Washington, Seattle, WA 98195.
Ashwini S Kamath-LoebDepartment of Pathology, University of Washington, Seattle, WA 98195.
Brendan F KohrnDepartment of Pathology, University of Washington, Seattle, WA 98195.ORCID 0000-0001-9948-2131
Keith R LoebDepartment of Pathology, University of Washington, Seattle, WA 98195.
Bradley D PrestonDepartment of Pathology, University of Washington, Seattle, WA 98195.
Lawrence A LoebDepartment of Pathology, University of Washington, Seattle, WA 98195; laaloeb@gmail.com.ORCID 0000-0001-6291-4498
University of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI SIDOROVA, JULIA · 1999 to 2019
$26.0M
CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BERNSTEIN, IRWIN D · 1999 to 2014
$14.9M
Mutator Phenotype in Colon CancerR01CA193649 · NCI · UNIVERSITY OF WASHINGTON · PI LOEB, LAWRENCE A · 2016 to 2019
$1.4M
NCI NIH HHS P01 CA077852NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA193649NIDDK NIH HHS P30 DK056465
6 · The paper itself

Abstract

The super-enhancers (SEs) of lineage-specific genes in B cells are off-target sites of somatic hypermutation. However, the inability to detect sufficient numbers of mutations in normal human B cells has precluded the generation of a high-resolution mutational landscape of SEs. Here we captured and sequenced 12 B cell SEs at single-nucleotide resolution from 10 healthy individuals across diverse ethnicities. We detected a total of approximately 9,000 subclonal mutations (allele frequencies <0.1%); of these, approximately 8,000 are present in the

Indexed as

AdultAICDA (Activation-Induced Cytidine Deaminase)B-LymphocytesCell LineCytidine DeaminaseDNA-Directed DNA PolymeraseDNA Mutational AnalysisEnhancer Elements, GeneticGene FrequencyGenetic LociHealthy VolunteersHumansLymphoma, B-CellMiddle AgedMutation RateProto-Oncogene Proteins c-bcl-6AICDA (Activation-Induced Cytidine Deaminase)BCL6 protein, humanCytidine DeaminaseDNA-Directed DNA PolymeraseProto-Oncogene Proteins c-bcl-6Rad30 proteinY-Family DNA PolymerasesBCL6duplex sequencingmutational signaturessomatic hypermutationsuper-enhancer

Identifiers

PMID31748270
PMCPMC6900602
OpenAlexW2991054028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.